Blood test could lead to cystic fibrosis treatment tailored to each patient

Researchers have used a blood test and microarray technology to identify distinct molecular signatures in children with cystic fibrosis. These patterns of gene expression ultimately could help predict disease severity and treatment response, and lead to therapies tailored to each patient’s precise biology.

Leave a Reply

Your email address will not be published.